2024
Alteplase (rtPA) remains the standard thrombolytic drug for acute ischemic stroke. However, new rtPA-derived molecules, such as tenecteplase (TNK), with (…)
Consulter
2024
Intracerebral aneurysms (IAs) are pathological dilatations of cerebral arteries whose rupture leads to subarachnoid hemorrhage, a significant cause of disability (…)
Consulter
2024
Recanalization is the mainstay of ischemic stroke treatment. However, even with timely clot removal, many stroke patients recover poorly. Leptomeningeal (…)
Consulter
2024
Tissue-plasminogen activator (tPA) is a serine protease well known for its fibrinolytic function. Recent studies indicate that tPA could also (…)
Consulter
2024
There are several cellular and acellular structural barriers associated with the brain interfaces, which include the dura, the leptomeninges, the (…)
Consulter
2024
Consulter